Rhumbline Advisers Enzo Biochem Inc Transaction History

Rhumbline Advisers

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$2.86 - $3.61 $214,943 - $271,309	-75,155 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$2.61 - $4.08 $6,316 - $9,873	-2,420 Reduced 3.12%	75,155 $259,000
Q4 2020 Feb 10, 2021	BUY	$1.82 - $2.61 $16,942 - $24,296	9,309 Added 13.64%	77,575 $195,000
Q3 2020 Nov 12, 2020	SELL	$2.02 - $3.02 $19,064 - $28,502	-9,438 Reduced 12.15%	68,266 $144,000
Q2 2020 Aug 13, 2020	BUY	$2.12 - $3.22 $12,635 - $19,191	5,960 Added 8.31%	77,704 $174,000
Q4 2019 Feb 05, 2020	SELL	$2.57 - $3.68 $670 - $960	-261 Reduced 0.36%	71,744 $189,000
Q3 2019 Oct 23, 2019	BUY	$3.01 - $4.0 $17,202 - $22,860	5,715 Added 8.62%	72,005 $259,000
Q2 2019 Aug 14, 2019	BUY	$2.79 - $4.31 $19,259 - $29,751	6,903 Added 11.62%	66,290 $223,000
Q1 2019 May 01, 2019	SELL	$2.54 - $4.02 $2,933 - $4,643	-1,155 Reduced 1.91%	59,387 $162,000
Q4 2018 Jan 31, 2019	BUY	$2.46 - $4.2 $47,185 - $80,560	19,181 Added 46.37%	60,542 $168,000
Q3 2018 Nov 07, 2018	SELL	$3.81 - $5.53 $10,858 - $15,760	-2,850 Reduced 6.45%	41,361 $170,000
Q2 2018 Aug 06, 2018	BUY	$5.06 - $6.78 $20,012 - $26,814	3,955 Added 9.82%	44,211 $229,000
Q1 2018 May 02, 2018	SELL	$5.43 - $8.36 $5,837 - $8,987	-1,075 Reduced 2.6%	40,256 $221,000
Q4 2017 Feb 09, 2018	SELL	$8.15 - $10.55 $68,834 - $89,105	-8,446 Reduced 16.97%	41,331 $337,000
Q3 2017 Nov 06, 2017	BUY	$10.45 - $11.44 $520,169 - $569,448	49,777	49,777 $521,000

15.5M

2.3K

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $48.7M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.